Is a complete TRIB research report available?

No complete published report is available for Trinity Biotech plc (TRIB) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Trinity Biotech plc (TRIB)

NASDAQ: TRIB · USD

$6.56

-0.24 (-3.5%)· Recorded snapshot

Market cap	5.3M
Revenue (ttm)	43.8M
Net income (ttm)	-37.4M
EPS (ttm)	-$60.4
Shares out	813.1K
Volume	12,239.401
Beta	0.97

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 43.8M
Net income (ttm): -37.4M
EPS (ttm): -$60.4
Market cap: 5.3M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Trzymaj

Metric	Value
Amount currency	USD
CIK code	0000888721
Company name	Trinity Biotech plc
Country	Ireland
Country code	US
CUSIP number	896438603
Earnings date	2026-12-22
Earnings time	bmo
Employees	287
Employees change	-114
Employees growth	-28.43%
Enterprise value	$138.2M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2025-12-31
First seen	2026-05-09
Fiscal year end	December
Founded	1992
Industry	Medical Devices
Is primary listing	Yes
Is SPAC	No
ISIN number	US8964386036
Last 10-K release date	2026-04-30
Last earnings date	2026-06-16
Last refreshed	2026-11-04
Last stock split date	2026-07-24
Last stock split type	Reverse
Market cap	$5.3M
Market cap category	Nano-Cap
Next earnings date	2026-12-22
Options	Yes
Price	$6.56
Price currency	USD
Sector	Healthcare
SIC code	2835
Stock price date	2026-11-03
Symbol	TRIB
Website	https://www.trinitybiotech.com

Metric

Value

Amount currency

USD

CIK code

0000888721

Company name

Trinity Biotech plc

Country

Ireland

Country code

CUSIP number

896438603

Earnings date

2026-12-22

Earnings time

bmo

Employees

287

Employees change

-114

Employees growth

-28.43%

Enterprise value

$138.2M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2025-12-31

First seen

2026-05-09

Fiscal year end

December

Founded

1992

Industry

Medical Devices

Is primary listing

Yes

Is SPAC

ISIN number

US8964386036

Last 10-K release date

2026-04-30

Last earnings date

2026-06-16

Last refreshed

2026-11-04

Last stock split date

2026-07-24

Last stock split type

Reverse

Market cap

$5.3M

Market cap category

Nano-Cap

Next earnings date

2026-12-22

Options

Yes

Price

$6.56

Price currency

USD

Sector

Healthcare

SIC code

2835

Stock price date

2026-11-03

Symbol

TRIB

Website

https://www.trinitybiotech.com

Metric	Value
Earnings yield	-920.17%
EV/Sales	3.16x
FCF / EV yield	-4.35%
FCF yield	-112.8%
Industry forward P/E	20.29x
Industry P/E	41.22x
P/S ratio	0.12x
Sector forward P/E	23.32x
Sector P/E	49.47x

Metric

Value

Earnings yield

-920.17%

EV/Sales

3.16x

FCF / EV yield

-4.35%

FCF yield

-112.8%

Industry forward P/E

20.29x

Industry P/E

41.22x

P/S ratio

0.12x

Sector forward P/E

23.32x

Sector P/E

49.47x

Metric	Value
EBIT margin	-21.8%
EBITDA margin	-18.83%
Gross margin	38.57%
Operating margin	-21.8%
Pretax margin	-84.91%
Profit margin	-85.36%
Profit per employee	$-130,230
Revenue per employee	$152,561
ROA	-5.72%
ROA (5Y)	-6.83%
ROCE	26.48%
ROIC	-57.55%
ROIC (5Y)	-24.63%
SBC / revenue	0.74%
Tax / revenue	0.45%

Metric

Value

EBIT margin

-21.8%

EBITDA margin

-18.83%

Gross margin

38.57%

Operating margin

-21.8%

Pretax margin

-84.91%

Profit margin

-85.36%

Profit per employee

$-130,230

Revenue per employee

$152,561

ROA

-5.72%

ROA (5Y)

-6.83%

ROCE

26.48%

ROIC

-57.55%

ROIC (5Y)

-24.63%

SBC / revenue

0.74%

Tax / revenue

0.45%

Metric	Value
EPS growth years	0
Gross profit growth	-21.24%
Gross profit growth 3Y	-0.74%
Gross profit growth 5Y	-19.05%
Net income growth years	0
Revenue growth	-28.87%
Revenue growth (QoQ)	-22.64%
Revenue growth 10Y	-7.94%
Revenue growth 3Y	-11.2%
Revenue growth 5Y	-15.56%
Revenue growth years	0

Metric

Value

EPS growth years

Gross profit growth

-21.24%

Gross profit growth 3Y

-0.74%

Gross profit growth 5Y

-19.05%

Net income growth years

Revenue growth

-28.87%

Revenue growth (QoQ)

-22.64%

Revenue growth 10Y

-7.94%

Revenue growth 3Y

-11.2%

Revenue growth 5Y

-15.56%

Revenue growth years

Metric	Value
Capital expenditures	$-88,000
Depreciation and amortization	$1.3M
EBIT	$-9.5M
EBITDA	$-8.2M
EPS	$-60.36
FCF per share	$-7.40
Financing cash flow	$12.1M
Free cash flow	$-6M
Free cash flow minus SBC	$-6.3M
Gross profit	$16.9M
Income taxes	$199,000
Investing cash flow	$-6.2M
Net borrowing	$11.8M
Net cash flow	$-29,000
Net income	$-37.4M
Operating cash flow minus SBC	$-6.3M
Operating income	$-9.5M
Revenue	$43.8M
Stock-based compensation	$324,000

Metric

Value

Capital expenditures

$-88,000

Depreciation and amortization

$1.3M

EBIT

$-9.5M

EBITDA

$-8.2M

EPS

$-60.36

FCF per share

$-7.40

Financing cash flow

$12.1M

Free cash flow

$-6M

Free cash flow minus SBC

$-6.3M

Gross profit

$16.9M

Income taxes

$199,000

Investing cash flow

$-6.2M

Net borrowing

$11.8M

Net cash flow

$-29,000

Net income

$-37.4M

Operating cash flow minus SBC

$-6.3M

Operating income

$-9.5M

Revenue

$43.8M

Stock-based compensation

$324,000

Metric	Value
Altman Z-Score	-2.58
Book value per share	$-115.42
Goodwill	$14M
Interest coverage	-0.75
Long-term assets	$69.3M
Long-term liabilities	$35.9M
Net cash (debt)	$-132.8M
Net cash / market cap	-2,490.46%
Piotroski F-Score	3
Property, plant and equipment	$5.3M
Shareholders' equity	$-72M
Tangible book value	$-105.4M
Tangible book value per share	$-169.00
Total assets	$105.2M
Total cash	$5.1M
Total debt	$138M
Total liabilities	$177.1M
WACC	7.41%

Metric

Value

Altman Z-Score

-2.58

Book value per share

$-115.42

Goodwill

$14M

Interest coverage

-0.75

Long-term assets

$69.3M

Long-term liabilities

$35.9M

Net cash (debt)

$-132.8M

Net cash / market cap

-2,490.46%

Piotroski F-Score

Property, plant and equipment

$5.3M

Shareholders' equity

$-72M

Tangible book value

$-105.4M

Tangible book value per share

$-169.00

Total assets

$105.2M

Total cash

$5.1M

Total debt

$138M

Total liabilities

$177.1M

WACC

7.41%

Metric	Value
Asset turnover	0.42
Current assets	$35.9M
Current liabilities	$141.2M
Current ratio	0.25
Inventory turnover	1.41
Net working capital	$368,000
Quick ratio	0.11
Working capital	$-105.3M
Working capital turnover	-0.91

Metric

Value

Asset turnover

0.42

Current assets

$35.9M

Current liabilities

$141.2M

Current ratio

0.25

Inventory turnover

1.41

Net working capital

$368,000

Quick ratio

0.11

Working capital

$-105.3M

Working capital turnover

-0.91

Metric	Value
Buyback yield / dilution	-3.43%
Dividend growth (3Y)	13.62%
Dividend per share	$0.00
Dividend yield	0%
Last dividend	$33.00
Shareholder yield	-3.43%

Metric

Value

Buyback yield / dilution

-3.43%

Dividend growth (3Y)

13.62%

Dividend per share

$0.00

Dividend yield

Last dividend

$33.00

Shareholder yield

-3.43%

Metric	Value
10Y price change	-99.35%
10Y return CAGR	-39.59%
10Y total return	-99.35%
150-day SMA	$13.00
15Y price change	-99.57%
15Y return CAGR	-30.25%
15Y total return	-99.55%
1D price change	-3.53%
1M price change	15.29%
1M total return	15.29%
1W price change	-8.25%
1W total return	-8.25%
1Y price change	-78.13%
1Y return CAGR	-78.16%
1Y total return	-78.13%
20-day SMA	$7.05
200-day SMA	$15.28
20Y price change	-99.51%
20Y return CAGR	-23.16%
20Y total return	-99.49%
3M price change	-43.45%
3M total return	-43.45%
3Y price change	-90.24%
3Y return CAGR	-53.95%
3Y total return	-90.24%
50-day SMA	$7.54
50-day SMA vs 200-day SMA	50under200
52-week high	$52.50
52-week high date	2025-12-23
52-week low	$5.01
52-week low date	2026-10-01
5Y price change	-97.78%
5Y return CAGR	-53.31%
5Y total return	-97.78%
6M price change	-64.01%
6M total return	-64.01%
After-hours change	-3.35%
After-hours close	$6.56
After-hours price	$6.34
All-time high	$4,556.26
All-time high date	2000-03-10
All-time low	$5.01
All-time low date	2026-10-01
Average true range (ATR)	$0.74
Average volume	15.1K
Beta (1Y)	3.43
Beta (2Y)	2.71
Beta (5Y)	0.97
Change from 52-week high	-87.5%
Change from 52-week low	30.94%
Change from all-time high	-99.86%
Change from all-time low	30.94%
Change from open	-3.53%
Day's gap	0%
Dollar volume	$80,290
High price	$6.80
Low price	$6.32
Monthly RSI	34.97
Open price	$6.80
Position in 52-week range	50%
Previous close	$6.80
Price vs 150-day SMA	-49.52%
Price vs 20-day SMA	-6.9%
Price vs 200-day SMA	-57.05%
Price vs 50-day SMA	-13%
Relative volume	0.81
RSI	42.96
Sharpe ratio	-0.81
Sharpe ratio (3Y)	-0.09
Sharpe ratio (5Y)	-0.28
Sortino ratio	-1.19
Sortino ratio (3Y)	-0.1
Sortino ratio (5Y)	-0.43
Volume	12.2K
Weekly RSI	35.51
YTD price change	-72.36%
YTD total return	-72.36%

Metric

Value

10Y price change

-99.35%

10Y return CAGR

-39.59%

10Y total return

-99.35%

150-day SMA

$13.00

15Y price change

-99.57%

15Y return CAGR

-30.25%

15Y total return

-99.55%

1D price change

-3.53%

1M price change

15.29%

1M total return

15.29%

1W price change

-8.25%

1W total return

-8.25%

1Y price change

-78.13%

1Y return CAGR

-78.16%

1Y total return

-78.13%

20-day SMA

$7.05

200-day SMA

$15.28

20Y price change

-99.51%

20Y return CAGR

-23.16%

20Y total return

-99.49%

3M price change

-43.45%

3M total return

-43.45%

3Y price change

-90.24%

3Y return CAGR

-53.95%

3Y total return

-90.24%

50-day SMA

$7.54

50-day SMA vs 200-day SMA

50under200

52-week high

$52.50

52-week high date

2025-12-23

52-week low

$5.01

52-week low date

2026-10-01

5Y price change

-97.78%

5Y return CAGR

-53.31%

5Y total return

-97.78%

6M price change

-64.01%

6M total return

-64.01%

After-hours change

-3.35%

After-hours close

$6.56

After-hours price

$6.34

All-time high

$4,556.26

All-time high date

2000-03-10

All-time low

$5.01

All-time low date

2026-10-01

Average true range (ATR)

$0.74

Average volume

15.1K

Beta (1Y)

3.43

Beta (2Y)

2.71

Beta (5Y)

0.97

Change from 52-week high

-87.5%

Change from 52-week low

30.94%

Change from all-time high

-99.86%

Change from all-time low

30.94%

Change from open

-3.53%

Day's gap

Dollar volume

$80,290

High price

$6.80

Low price

$6.32

Monthly RSI

34.97

Open price

$6.80

Position in 52-week range

50%

Previous close

$6.80

Price vs 150-day SMA

-49.52%

Price vs 20-day SMA

-6.9%

Price vs 200-day SMA

-57.05%

Price vs 50-day SMA

-13%

Relative volume

0.81

RSI

42.96

Sharpe ratio

-0.81

Sharpe ratio (3Y)

-0.09

Sharpe ratio (5Y)

-0.28

Sortino ratio

-1.19

Sortino ratio (3Y)

-0.1

Sortino ratio (5Y)

-0.43

Volume

12.2K

Weekly RSI

35.51

YTD price change

-72.36%

YTD total return

-72.36%

Metric	Value
Float	673.8K
Float percentage	82.86%
Shares change (QoQ)	0.3%
Shares change (YoY)	3.43%
Shares held by insiders	2.03%
Shares held by institutions	3.61%
Shares outstanding	813.1K
Short % of shares	9.9%
Short ratio	2.3 days

Metric

Value

Float

673.8K

Float percentage

82.86%

Shares change (QoQ)

0.3%

Shares change (YoY)

3.43%

Shares held by insiders

2.03%

Shares held by institutions

3.61%

Shares outstanding

813.1K

Short % of shares

9.9%

Short ratio

2.3 days

Trinity Biotech plc (TRIB)

Price

Financial snapshot

Fair-value bridge

Latest news · TRIB

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TRIB indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on TRIB

Frequently asked questions